Skip to search formSkip to main contentSkip to account menu

Osteoporosis, Postmenopausal

Known as: Postmenopausal Bone Losses, Bone Losses, Perimenopausal, Osteoporoses, Post-Menopausal 
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after… 
National Institutes of Health

Related topics

Related topics

46 relations
10 ML Pamidronate Disodium 3 MG/ML Injection10 ML Pamidronate Disodium 9 MG/ML Injection84 HR Estradiol 0.00156 MG/HR Transdermal System [Vivelle]84 HR Estradiol 0.00208 MG/HR Transdermal System [Alora]

Broader (1)

Osteoporosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
BACKGROUND A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in… 
Review
2005
Review
2005
Crop losses to pests
  • E. Oerke
  • Journal of Agricultural Sciences
  • 2005
  • Corpus ID: 51771047
Productivity of crops grown for human consumption is at risk due to the incidence of pests, especially weeds, pathogens and… 
Highly Cited
2004
Highly Cited
2004
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
BACKGROUND Osteoporotic structural damage and bone fragility result from reduced bone formation and increased bone resorption. In… 
Review
2002
Review
2002
Exercise for preventing and treating osteoporosis in postmenopausal women.
BACKGROUND Osteoporosis is a condition resulting in an increased risk of skeletal fractures due to a reduction in the density of… 
Highly Cited
2001
Highly Cited
2001
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
BACKGROUND Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass… 
Highly Cited
2000
Highly Cited
2000
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
Abstract: The purpose of this randomized, double-masked, placebo-controlled study was to determine the efficacy and safety of… 
Highly Cited
1999
Highly Cited
1999
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT…
CONTEXT Risedronate, a potent bisphosphonate, has been shown to be effective in the treatment of Paget disease of bone and other… 
Review
1998
Review
1998
A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men
We propose here a new unitary model for the pathophysiology of involutional osteoporosis that identifies estrogen (E) deficiency… 
Highly Cited
1995
Highly Cited
1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
BACKGROUND Postmenopausal osteoporosis is a serious health problem, and additional treatments are needed. METHODS We studied… 
Review
1993
Review
1993
Users' guides to the medical literature.
Medical practice is constantly changing. The rate of change is accelerating, and physicians can be forgiven if they often find it… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)